US OPEN: Dow set to drop 800 points at session launch

4:35 pm 24 February 2020

  • Futures point to a carnage at Wall Street open

  • Bernie Sanders wins Democratic Party primaries in Nevada

  • Buffett does not see current M&A valuations as opportunity

Surge in the number of new coronavirus cases outside China has doomed equities in Asia and Europe today. US equities are unlikely to buck this trend as the futures market points to the S&P 500 index opening 2.3% lower. In other news, Bernie Sanders scored a big win in Nevada primaries while Warren Buffett’s Berkshire Hathaway released full-year results.

Bernie Sanders wins Nevada primaries

Start investing today or test a free demo

Open real account TRY DEMO Download mobile app Download mobile app

Bernie Sanders won Democratic primaries in Nevada, securing a support of 47.1%. Joe Biden received 21% of the votes while Pete Buttigeg had a support of 13.7%. The results cover 88% of the votes. Sanders has won all three primaries that were already held (Iowa, New Hampshire and Nevada) and is on his way to become November’s challenger to incumbent president Donald Trump. However, Nevada results may be misleading as Sanders’ biggest competitor - Michael Bloomberg) did not take part in primaries in the state. The real test for Sanders and Bloomberg will be next week, when the so-called Super Tuesday is held (Tuesday, March 3). Primaries will be run in 14 states on this day and support of 34% of all delegates is at stake. 

US30 (Dow Jones futures underlying) is trading 2.5% lower today. The index tests the key support ranging between 28150 pts handle and the lower limit of the Overbalance structure (yellow box). The zone is additionally being strengthened by the 100-session moving average (red line). Unless some upbeat news on coronavirus see daylight later today, index’ trading may be focused on the aforementioned 28150 pts handle throughout the session. Source: xStation5

Berkshire Hathaway (BRKB.US) published Q4 and full-2019 earnings on Saturday. Company’s Q4 adjusted net profit of $4.42 billion was almost 30% lower than the median estimate compiled by Bloomberg. However, the company booked a $24.7 billion one-off gain, putting its unadjusted net profit at $29.16 billion. Revenue of $65.368 billion, trailed estimate by 1.7%. Full-2019 revenue grew 2.7% to $254.62 billion. Full-year net income of $23.972 billion was 45% higher than expected and 3.2% YoY lower.

Warren Buffett, chairman of the Berkshire Hathaway, expressed regret in his annual letter to shareholders over inability to find the next big acquisition. Buffett said that current M&A valuations do not create an opportunity and his company is likely to resort to buying smaller, non-controlling stakes in companies. The letter also renewed discussion over succession as chairman Buffett will turn 90 this year while vice-chairman Munger turned 96 on New Year’s Eve. In the letter Buffett said that two executives holding vice-chairman roles - Ajit Jain and Greg Abel - will have their presence increased at the incoming annual shareholder meeting in May. The two are has been named as potential successors to Buffett for some time already but this year’s letter did not hint on who is the front-runner.

Berkshire Hathaway (BRKB.US) bounced off the 50-session moving average (green line) at the end of the previous week. However, the stock is still trading below intraday ATH of €231.6 reached on January 17. The company's adjusted beta calculated with monthly returns over the previous 30 years stands at 0.73, hinting that Berkshire Hathaway may be more resilient than S&P 500 today. However, in case the market's plunge continues to gather pace, the stock may be set to test support at $223. Source: xStation5

Global stock markets are being roiled by coronavirus concerns. However, it does not mean that each and every stock is trading lower. Investors pour their money into shares of medical companies that announced they are working on vaccines for the novel coronavirus. Novavax (NVAX.US) is one such company. Shares are benefiting from recent rise in new coronavirus cases and trade over 15% higher in premarket. Co-Diagnostics (CODX.US) is also on the rise with shares trading 10% higher in premarket. The company recently submitted a COVID-19 diagnostic test for registration in Europe.

While miner stocks are sinking with commodities today, there is a group of miners that buck the trend - companies involved in precious metals mining. Newmont (NEM.US), the world’s largest gold miner, is an example. The company trades around 5% higher today, being fuelled by gold price surge and upbeat recommendation from CIBC. Analysts praised the company's earnings announced last week and decided to boost recommendation from “neutral” to “outperform”.

Newmont (NEM.US) gains on the ongoing gold market rally. Gold miner failed to reach the $50 resistance zone at the end of the previous week. However, premarket trades point to open near $52 handle, thanks to a 2% increase in gold price today. In such a scenario, the aforementioned $50 zone could serve as a floor today. The next major resistance in line is zone at 78.6% Fibo level of a drop started in late-2011. Source: xStation5

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back
Xtb logo

Join over 1 000 000 XTB Group Clients from around the world.

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
__hssc cc 8 September 2022
SESSID cc 2 March 2024
__cf_bm cc 8 September 2022
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
__hstc cc 7 March 2023
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
hubspotutk cc 7 March 2023

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language